CDC update

May 2, 2022
This message includes updates on the COVID-19 response from CDC. The COVID-19 Outbreak is a rapidly evolving situation and information will be updated as it becomes available.



COVID-19 Preventive Medication
Evusheld is an investigational medicine that can help protect you from getting COVID-19. You may be eligible for Evusheld if you:
Are moderately or severely immunocompromised and may not mount an adequate immune response to COVID-19 vaccination OR have a history of severe allergic reactions to COVID-19 vaccines, and
Do not currently have COVID-19 and have not recently had close contact with someone with COVID-19, and
Are an adult or adolescent ages 12 years and older weighing at least 88 pounds (40 kg).
Evusheld contains two different antibodies that can help prevent COVID-19. It must be given by your healthcare provider before exposure to COVID-19.


Talk to your healthcare provider to find out if this option is right for you. Even if you receive Evusheld, taking multiple prevention steps, such as wearing a well-fitting mask or respirator and avoiding crowded places, can provide additional layers of protection from COVID-19.

Learn More



COVID-19 Treatments and Medications
For people who are more likely to get very sick from COVID-19 infection, medications are available that can reduce the chances of severe illness and death. Other medications can help reduce symptoms and help manage the illness.


People who are more likely to get very sick include older adults (ages 50 years or more, with risk increasing with older age), people who are unvaccinated, and people with certain medical conditions, such as a weakened immune system.


Being vaccinated makes you much less likely to get very sick. Still, some vaccinated people, especially those ages 65 years or older or who have other risk factors for severe disease, may benefit from treatment if they get COVID-19. A healthcare provider will help decide which treatment, if any, is right for each individual.


The FDA has issued emergency use authorizations (EUA) for certain antiviral medications and monoclonal antibodies to treat mild to moderate COVID-19 in people who are more likely to get very sick.

Learn More



What You Need to Know About Variants

Viruses constantly change through mutation and sometimes these mutations result in a new variant of the virus. Some variants emerge and disappear while others persist. New variants will continue to emerge. CDC and other public health organizations monitor all variants of the virus that cause COVID-19 in the United States and globally.

Scientists monitor all variants but may classify certain ones as variants being monitored, variants of interest, variants of concern and variants of high consequence. Some variants spread more easily and quickly than other variants, which may lead to more cases of COVID-19.

Even if a variant causes less severe disease in general, an increase in the overall number of cases could cause an increase in hospitalizations, put more strain on healthcare resources and potentially lead to more deaths.


Learn More



COVID Data Tracker Weekly Review

As of April 29, 2022, more than 100 million people in the United States. have received their first COVID-19 booster. Staying up to date with vaccines is the safest way to protect yourself from getting very sick with COVID-19—even if you've already had COVID-19.
Learn More
Subscribe


COVID-19 Community Levels

CDC uses COVID-19 Community Levels to determine the disease’s impact on counties and rec
CDC also tracks cases, laboratory tests, vaccinations, deaths, and other pandemic data and provides them on our COVID Data Tracker.





Community Levels

May 2, 2022

PLACES provides model-based, population-level analysis and community estimates of health measures to all counties, places, census tracts, and ZIP Code Tabulation Areas (ZCTAs) across the United States. Learn more about PLACES.

Updated PLACES Web Page

The PLACES web page has been redesigned! The new design streamlines access to data and help materials, including videos, how to guides, and FAQs.	Click here to view the updated PLACES Help page!

2022 Release of Chronic Disease Indicators

	Chronic disease indicators (CDI) provides state-level estimates of chronic disease measures that complement local PLACES estimates. CDI includes measures across 18 topic areas, with 124 indicators and over 200 measures.

May Health Observances

Arthritis Awareness  Month Estimates of the prevalence of arthritis can be found in the PLACES Interactive Map and Data Portal. CDC and its partners encourage you to learn more about its recognized interventions for arthritis and other chronic diseases.	Mental Health  Awareness Month Two recently added estimates of the prevalence of depression and mental health not good for >14 days can be found in the PLACES Interactive Map and Data Portal. Find more resources from CDC on Emotional Well-Being and Mental Health.

PLACES in Practice  City Health Dashboard provides city- and census tract-level data on more than 40 measures of health outcomes, determinants, and equity. It covers over 750 cities across the United States. Recently, a COVID Local Risk Index was added that uses PLACES data along with other data to estimate the risk of COVID-19 transmission and severe infection in a city or neighborhood. How is your team using PLACES data? Please share your stories and experience with us by emailing PLACES@cdc.gov. You can also send questions to this mailbox.  Click here to email the PLACES team!

More Information

PLACES Data Portal	FAQs	PLACES Interactive Map	Help section

Centers for Disease Control and Prevention